This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

The Dialysis Encephalopathy Syndrome — Possible Aluminum Intoxication

List of authors.
  • Allen C. Alfrey, M.D.,
  • Gary R. LeGendre, M.S.,
  • and William D. Kaehny, M.D.

Abstract

The aluminum content of muscle, bone and brain was measured in control subjects and in uremic patients on dialysis who had been maintained on phosphate-binding aluminum gels. The mean muscle aluminum was 14.8 ppm, and the trabecular-bone aluminum 98.5 ppm in the patients on dialysis, as compared with 1.2 and 2.4 in control subjects (P < 0.05). Brain gray-matter aluminum values in a group of uremic patients on dialysis who died of a neurologic syndrome of unknown cause were 25 ppm as compared with 6.5 ppm in a group of uremic patients on dialysis who died of other causes and 2.2 ppm in control subjects. The fact that brain gray-matter aluminum was higher in all patients with the dialysis-associated encephalopathy syndrome than any of the control subjects or other uremic patients on dialysis suggests that this syndrome may be due to aluminum intoxication. (N Engl J Med 294:184–188, 1976)

Funding and Disclosures

Supported by a contract (No. 1-AM-4–2217) with the National Institutes of Health, by the Veterans Administration and by a grant from the Rocky Mountain Kidney Foundation.

Author Affiliations

From the Renal Section, Denver Veterans Administration Hospital, and the Division of Renal Medicine, University of Colorado Medical Center, Denver, Colorado (address reprint requests to Dr. Alfrey at the Renal Section, Veterans Administration Hospital, 1055 Clermont St., Denver, CO 80220).